Comments: The ethics of disease-modifying drugs targeting Alzheimer disease: response to our commentators (vol.47, issue 9, page :608–614)
Journal of medical ethics, 2022, Vol.48 (3) [Peer Reviewed Journal]ISSN: 0306-6800 ;ISSN: 1473-4257 ;EISSN: 1473-4257 ;DOI: 10.1136/medethics-2022-108157
Full text available